Several studies have been conducted in the context of liver fibrosis, suggesting that αMSH reduces markers of fibrosis in the carbon tetrachloride (CCl4) and in the thioacetamide-induced mouse models of liver fibrosis (190, 191). Here, STAMBP is linked to Hepatic fibrosis.